BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 33091676)

  • 1. Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.
    Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Davies Forsman L; Schön T; Bruchfeld J; Alffenaar JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122397. PubMed ID: 33091676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
    Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
    APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
    Wu L; Ye Z; Liu H; Guo H; Lin J; Zheng L; Chu N; Liu X
    J Pharm Biomed Anal; 2020 Feb; 180():113076. PubMed ID: 31896523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of the potent anti-tuberculosis regimen-Pyrazinamide, ethambutol, protionamide, clofazimine in beagle dog plasma using LC-MS/MS method coupled with 96-well format plate.
    Wu S; Lan L; Jiang J; Ding X; Ho CM; Lou Y; Fan G
    J Pharm Biomed Anal; 2019 May; 168():44-54. PubMed ID: 30784889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
    Fachi MM; Vilhena RO; Boger B; Domingos EL; Dos Santos JMMF; Junkert AM; de Fátima Cobre A; Momade DRO; Beraldi-Magalhães F; de Liz MV; Cordeiro-Santos M; Pontarolo R
    Biomed Chromatogr; 2020 May; 34(5):e4812. PubMed ID: 32068899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
    Mercier T; Desfontaine V; Cruchon S; Da Silva Pereira Clara JA; Briki M; Mazza-Stalder J; Kajkus A; Burger R; Suttels V; Buclin T; Opota O; Koehler N; Sanchez Carballo PM; Lange C; André P; Decosterd LA; Choong E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123456. PubMed ID: 36240540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Kim HJ; Seo KA; Kim HM; Jeong ES; Ghim JL; Lee SH; Lee YM; Kim DH; Shin JG
    J Pharm Biomed Anal; 2015 Jan; 102():9-16. PubMed ID: 25218029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid and robust liquid chromatography/tandem mass spectrometry method for simultaneous analysis of anti-tuberculosis drugs--ethambutol and pyrazinamide in human plasma.
    Gong Z; Basir Y; Chu D; McCort-Tipton M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(16-17):1698-704. PubMed ID: 19419912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
    Gao S; Wang Z; Xie X; You C; Yang Y; Xi Y; Chen W
    Tuberculosis (Edinb); 2018 Mar; 109():28-34. PubMed ID: 29559118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS method for the simultaneous determination of PA-824, moxifloxacin and pyrazinamide in rat plasma and its application to pharmacokinetic study.
    Wang L; Xu Y; Liang L; Diao C; Liu X; Zhang J; Zhang S
    J Pharm Biomed Anal; 2014 Aug; 97():1-8. PubMed ID: 24798753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a UPLC-MS/MS method for simultaneous quantification of levofloxacin, ciprofloxacin, moxifloxacin and rifampicin in human plasma: Application to the therapeutic drug monitoring in osteoarticular infections.
    LLopis B; Funck-Brentano C; Tissot N; Bleibtreu A; Jaureguiberry S; Fourniols E; Aubry A; Zahr N
    J Pharm Biomed Anal; 2020 May; 183():113137. PubMed ID: 32086125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
    Kivrane A; Grinberga S; Sevostjanovs E; Igumnova V; Pole I; Viksna A; Bandere D; Krams A; Cirule A; Pugovics O; Ranka R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122986. PubMed ID: 34688197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple and sensitive method for the analysis of 14 antituberculosis drugs using liquid chromatography/tandem mass spectrometry in human plasma.
    Lei Q; Zhao Y; Wang H; Zhou J; Lv X; Dang L; Zhu C
    Rapid Commun Mass Spectrom; 2020 Apr; 34(8):e8667. PubMed ID: 31800129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
    Zhou Z; Wu X; Wei Q; Liu Y; Liu P; Ma A; Zou F
    Anal Bioanal Chem; 2013 Jul; 405(19):6323-35. PubMed ID: 23719934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis.
    Lee SJ; Desta KT; Eum SY; Dartois V; Cho SN; Bae DW; Shin SC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():138-43. PubMed ID: 26730550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS.
    Han M; Jun SH; Lee JH; Park KU; Song J; Song SH
    J Antimicrob Chemother; 2013 Sep; 68(9):2066-73. PubMed ID: 23657802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples.
    Reckers A; Wen A; Aguilar D; Bacchetti P; Gandhi M; Metcalfe J; Gerona R
    J Vis Exp; 2020 May; (159):. PubMed ID: 32510502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput LC-MS/MS method for simultaneous determination of isoniazid, ethambutol and pyrazinamide in human plasma.
    Pršo K; Žideková N; Porvazník I; Solovič I; Mokrý J; Kertys M
    Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9425. PubMed ID: 36329637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and simultaneous determination of ten anti-tuberculosis drugs in human plasma by UPLC-MS/MS with applications in therapeutic drug monitoring.
    Wang X; Zhang H; Han Y; Huo L; Cao Y; Xu X; Ai L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122246. PubMed ID: 32668377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS/MS method.
    Paal M; Zoller M; Schuster C; Vogeser M; Schütze G
    J Pharm Biomed Anal; 2018 Apr; 152():102-110. PubMed ID: 29414000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.